Evidence map›Paper›PMID 39019909›Full record

ArticleScientific reports2024

Exploring phylogeny and genomic vulnerability of Melastoma (Melastomataceae) endemic to a World Natural Heritage site, the Bonin Islands.

Yukihiro Kobayashi, Yoshiteru Komaki, Yuji Isagi

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yukihiro KobayashiGraduate School of Agriculture, Kyoto University, Kyoto, Japan. ykoba1994@gmail.com.
Yoshiteru KomakiBotanical Gardens, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
Yuji IsagiGraduate School of Agriculture, Kyoto University, Kyoto, Japan. isagi.yuji.5n@kyoto-u.ac.jp.

Funding

Ministry of the Environment, Government of Japan JPMEERF20194002Ministry of the Environment, Government of Japan JPMEERF20204003Ministry of the Environment, Government of Japan JPMEERF20224M02
6 · The paper itself

Abstract

Melastoma (Melastomataceae) includes ca. 100 species across tropical to subtropical regions of Asia and Oceania. The Bonin Islands harbor three endemic taxa: M. tetramerum, M. tetramerum var. pentapetalum, and M. candidum var. alessandrense. Of these, M. tetramerum is critically endangered and faces near extinction in the wild. This study investigates the phylogenetic relationships among these endemic Melastoma species in the Bonin Islands based on the whole chloroplast genome and nuclear SNPs. The results revealed that M. candidum var. alessandrense was placed in the clade of the widespread East Asian M. candidum and has a distinct evolutionary origin from the other two taxa. The population genomics analyses (heterozygosity, rates of deleterious mutations, and numbers and lengths of runs of homozygosity) indicated lower genetic diversity and more vulnerable genomes of endemic Melastoma, especially M. tetramerum var. pentapetalum. M. tetramerum var. pentapetalum is not a target of any protection programs, however, conservation plans might be required for this variety because M. tetramerum var. pentapetalum would have a more vulnerable genome than M. tetramerum, which faces near extinction in the wild. This information can facilitate the development of effective conservation strategies in a precautionary way that anticipates imminent threats to the survival of the species.

Indexed as

MelastomataceaePhylogenyEndangered SpeciesGenetic VariationGenome, ChloroplastGenome, PlantGenomicsIslandsPolymorphism, Single NucleotideConservation genomicsEndangered speciesEndemic speciesPhylogeny

Identifiers

PMID39019909
PMCPMC11254903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.